Edwards Lifesciences Profit Margin

Edwards Lifesciences posts a profit margin of 15.43% as of June 2026. That compares with 72.96% in the prior-year period — down 78.8% year over year. That is below the Healthcare sector average of 15.58%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Edwards Lifesciences's profit margin was 72.96%. The latest reading is 15.43% — a 78.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 15.58% is typical. Edwards Lifesciences's 15.43% is lower that level. That is roughly 1.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Edwards Lifesciences's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 15.43% as of June 2026; use YoY and peer views to separate noise from signal.

Context for EW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.58%), and (3) consistency with growth and profitability. This page covers the first two; Edwards Lifesciences's other metric pages and overview cover the third.